Will new lawsuit delay commercialization of AquaBounty’s GM salmon?

AquaBounty Lawsuit just another attempt to delay commercialization of GE salmon strict xxl
Image: Food Navigator.

AquaBounty Technologies, which hopes to become the first company to introduce a genetically engineered animal to the human food supply, says a legal challenge to Environment Canada’s decision to approve its technology is just the latest attempt by its opponents to delay the commercialization process.

The company’s AquAdvantage salmon contains a growth hormone gene that allows the salmon to mature twice as fast as conventional salmon. In November 2013, Environment Canada concluded that the GE salmon was not harmful to human health or the environment. The application for a judicial review, filed by two environmental groups, alleges that the Canadian government failed to conduct a full risk assessment before giving AquaBounty the thumbs up.

“This has been the most transparent and rigorous process ever conducted,” said AquaBounty CEO Ron Stotish. “Multiple regulatory agencies in two countries have concluded multiple times that our salmon is environmentally safe. They are backed up by the consensus of the credible scientific community.”

“This law suit is nothing more than an attempt to continue to delay a process that has already taken 20 years,” he added.

Read the full, original article: AquaBounty: Lawsuit just another attempt to delay commercialization of GE salmon

Additional Resources:

{{ reviewsTotal }}{{ options.labels.singularReviewCountLabel }}
{{ reviewsTotal }}{{ options.labels.pluralReviewCountLabel }}
{{ options.labels.newReviewButton }}
{{ userData.canReview.message }}
screenshot at  pm

Are pesticide residues on food something to worry about?

In 1962, Rachel Carson’s Silent Spring drew attention to pesticides and their possible dangers to humans, birds, mammals and the ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
glp menu logo outlined

Get news on human & agricultural genetics and biotechnology delivered to your inbox.